Premium
Anterior hypothalamic β‐adrenoceptors in chronic aortic‐coarctated hypertensive rats: An interaction with central angiotensin II receptors
Author(s) -
Höcht Christian,
Opezzo Javier AW,
Gironacci Mariela M,
Peña Clara,
Taira Carlos A
Publication year - 2005
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.2005.04150.x
Subject(s) - atenolol , medicine , endocrinology , clenbuterol , blood pressure , propranolol , angiotensin ii , mean arterial pressure , agonist , receptor , renin–angiotensin system , chemistry , heart rate
SUMMARY 1. The aim of the present study was to investigate the activity of anterior hypothalamic β‐adrenoceptors and angiotensin (Ang) II receptors on blood pressure in normotensive rats and aortic‐coarctated (ACo) animals at a chronic stage of hypertension. A possible interaction between β‐adrenoceptors and AngII pressor activity was also investigated. 2. Injection of isoproterenol (0.1–10 nmol) in the anterior hypothalamic area induced a dose‐dependent decrease in mean arterial pressure (MAP) in sham‐operated (SO), but not in ACo, animals. Isoproterenol (1 nmol) reduced blood pressure in SO rats (ΔMAP −10.1 ± 1.4 mmHg; n = 10) but not in ACo animals (ΔMAP −0.9 ± 1.6 mmHg; n = 10; P < 0.05 vs SO rats). Whereas previous administration of atenolol (40 nmol) enhanced the cardiovascular effect of isoproterenol (1 nmol) in ACo rats but not in SO animals, propranolol (40 nmol) prevented the hypotensive action of isoproterenol in both experimental groups. Intrahypothalamic administration of clenbuterol decreased MAP in a dose‐dependent manner; however, the depressor response to clenbuterol (10 nmol) was greater in ACo rats than in SO rats (ΔMAP −26.8 ± 3.2 vs −14.4 ± 2.4 mmHg, respectively; n = 5 for both; P < 0.05). When AngII (50 ng) was injected into the anterior hypothalamic area, a greater pressor response was observed in ACo rats than in SO rats (ΔMAP 19.6 ± 1.1 vs 11.3 ± 0.6 mmHg, respectively; n = 5 for both; P < 0.05). Atenolol (40 nmol) pretreatment partially and significantly prevented the pressor response to AngII in ACo rats, but not in SO rats. 3. In conclusion, these results provide pharmacological evidence for the existence of a β 1 ‐adrenoceptor‐mediated pressor mechanism in the anterior hypothalamic area of ACo rats that is absent in SO rats. The enhanced depressor β 2 ‐adrenoceptor activity observed in chronic ACo rats could be a compensatory adjustment to pressor β 1 ‐adrenoceptor activity. Conversely, pressor overactivity of AngII was observed in the anterior hypothalamic area of ACo rats at a chronic hypertensive stage; this enhancement could be explained, at least in part, by the pressor β 1 ‐adrenoceptor activity.